The results showed the paradoxical patterns of expression of IDO; specifically, both a higher density of IDO+cells in TDLN and down-regulation of IDO in metastatic cancer cells were associated with poor prognosis in colon cancers. The gene discussed is IDO1; the disease is malignant colon neoplasm.